DFX Intelligence
Data Factory
Reading the graph
Reading the graph
unknown
South San Francisco, CA
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases. Our cutting-edge science is fully focused on developing therapeutics that intelligently target key drivers of the immune system to transform the treatment of inflammatory and immunologic diseases, and improve and empower countless lives. Join us in our quest.
Data as of (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built and rebuilt at most every 15 minutes.
| Announced | Round | Stage | Amount | Basis | Investors |
|---|---|---|---|---|---|
| Dec 27, 2024 | Form D equity offering | unknown | $150M | Form d sold | 20 |
| Investor | Class | Fund | Partner | Role | Attribution |
|---|---|---|---|---|---|
| The Column Group | Multi stage VC | n/a | n/a | unknown | Unknown |
| The Column Group | Multi stage VC | n/a | n/a | unknown | Unknown |
Also named here, with no published line of their own (reach them through the firm): Rodney J. Young (Executive Officer), Dirk J. Brockstedt (Executive Officer), William J. Ho (Executive Officer), Brian Wong (Executive Officer/Director), Wendye J. Robbins (Director), Linda J. Kozick (Director), Michael Giordano (Director), Mary Ann V. Gray (Director), William J. Rieflin (Director), Lori V. Lyons-Williams (Director).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan